Want access to multiple medication options: If you and your clinician want the flexibility to choose from branded GLP-1 injectables, oral options, non-GLP-1 medications, and compounded alternatives under one clinical umbrella, Found Health describes a wide range of medication options within its program
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Metabolism and excretion of the Once-Daily human Glucagon-Like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase
If your prescription doesnt get approved for any reason, youre given a full refund
You can download the full report here: To view or add a comment, sign in GLP-1 is part of everyday life for around 1.6 million people across the UK, and that number is steadily growing